《世界生物精神病学杂志》第12卷第5期

S. Kasper
{"title":"《世界生物精神病学杂志》第12卷第5期","authors":"S. Kasper","doi":"10.3109/15622975.2011.602222","DOIUrl":null,"url":null,"abstract":"Dear Colleagues, It is my pleasure to welcome you to the fi fth issue of 2011. Fabrice Jollant and colleagues present a review article on studies exploring dysfunctional cognitive processes and their neuroanatomical basis in suicidal behaviour in order to develop a neurocognitive working model. The concept of alterations in suicidal behaviour distinct from those of comorbid disorders is support. The authors come to the conclusion that several neurocognitive dysfunctions, some with trait-like characteristics, may facilitate the development of a suicidal crisis during stressful circumstances: an altered modulation of value attribution, an inadequate regulation of emotional and cognitive responses, and a facilitation of acts in an emotional context. This preliminary model may represent a framework for the design of future studies on the pathophysiology, prediction and prevention of these complex human behaviours. Lithium continues to be a cornerstone for the prophylaxis and treatment of bipolar disorder and is helpful for other related mental disorders, such as schizoaffective disorder and cyclic major depression. Lithium was introduced to modern psychiatry more than 60 years ago. On the occasion of this anniversary, Janusz Rybakowski presents an update on the most important original papers and reviews on lithium published in the recent years. The pro-cognitive and antisuicidal properties of lithium have been confi rmed as an augmentation of antidepressants in treatment-resistant depression. The neuroprotective effects of lithium have been evidenced in both experimental research and in clinical studies using brain imaging. The possible use of lithium in the prophylaxis of dementia and in neurodegenerative disorders, such as Huntington ' s disease and amyotrophic lateral sclerosis is discussed. Narc í s Cardoner and colleagues from Spain assessed 21 patients diagnosed with ObsessiveCompulsive Disorder (OCD) and 21 healthy controls with fMRI during an emotional face-processing paradigm involving active response generation to test for alterations in both brain activation and task-induced functional connectivity of the frontal cortex, the amygdala and the fusiform face area. The starting point of this study was that patients with anxiety symptoms generally overreact to emotional cues. The results clearly show that patients with OCD showed signifi cantly greater activation of “ face-processing ” regions including the amygdala, fusiform gyrus and dorsolateral prefrontal cortex. The reciprocal connectivity between face-processing regions was enhanced in OCD. Importantly it was detected that there are signifi cant correlations between patients ’ clinical symptom severity and both task-related region activation and network functional connectivity. Treatment Resistent Depression is a major challenge in everyday clinical practice. A few studies have suggested that switching between selective serotonin reuptake inhibitor (SSRI) and tricyclic (TCA) antidepressants may have positive effects on the treatment outcome. Thus Daniel Souery and colleagues have undertaken a prospective study to evaluate the impact of switching strategies. A total of 189 patients who failed to respond to previous antidepressant treatment were included for this study. The results support the thesis that switching from an SSRI to a TCA (and vice versa) in non-responders to a 4-week trial of an SSRI/ TCA is not associated with improved response. Recent studies have evidenced that patients with Bipolar Disorder (BD) show a sensory gating defi cit (P50). Among the neural systems that could be infl uencing this electrophysiological phenotype, dopamine seems to play an important role. In é s Anc í n and Spanish colleagues assume that catecholO -methyltransferase (COMT), the main metabolizer of dopamine in prefrontal cortex, is related to this defi cit. A case – control study was performed in 784 controls and 238 BD patients. Besides, 122 euthymic bipolar subjects and 95 healthy subjects carried out a sensory gating task (P50). The results support the association of the COMT gene with BD and with one of its potential endophenotypes, auditory sensory gating defi cit, measured by the P50 paradigm. Sheng-Yu Lee and colleages from Taiwan present a study on the dopaminergic polymorphims as risk factors for Bipolar Disorders (BD). The authors examined the association between the The World Journal of Biological Psychiatry, 2011; 12: 317–318","PeriodicalId":22963,"journal":{"name":"The World Journal of Biological Psychiatry","volume":"64 1","pages":"317 - 318"},"PeriodicalIF":0.0000,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The World Journal of Biological Psychiatry vol. 12, issue 5\",\"authors\":\"S. Kasper\",\"doi\":\"10.3109/15622975.2011.602222\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dear Colleagues, It is my pleasure to welcome you to the fi fth issue of 2011. Fabrice Jollant and colleagues present a review article on studies exploring dysfunctional cognitive processes and their neuroanatomical basis in suicidal behaviour in order to develop a neurocognitive working model. The concept of alterations in suicidal behaviour distinct from those of comorbid disorders is support. The authors come to the conclusion that several neurocognitive dysfunctions, some with trait-like characteristics, may facilitate the development of a suicidal crisis during stressful circumstances: an altered modulation of value attribution, an inadequate regulation of emotional and cognitive responses, and a facilitation of acts in an emotional context. This preliminary model may represent a framework for the design of future studies on the pathophysiology, prediction and prevention of these complex human behaviours. Lithium continues to be a cornerstone for the prophylaxis and treatment of bipolar disorder and is helpful for other related mental disorders, such as schizoaffective disorder and cyclic major depression. Lithium was introduced to modern psychiatry more than 60 years ago. On the occasion of this anniversary, Janusz Rybakowski presents an update on the most important original papers and reviews on lithium published in the recent years. The pro-cognitive and antisuicidal properties of lithium have been confi rmed as an augmentation of antidepressants in treatment-resistant depression. The neuroprotective effects of lithium have been evidenced in both experimental research and in clinical studies using brain imaging. The possible use of lithium in the prophylaxis of dementia and in neurodegenerative disorders, such as Huntington ' s disease and amyotrophic lateral sclerosis is discussed. Narc í s Cardoner and colleagues from Spain assessed 21 patients diagnosed with ObsessiveCompulsive Disorder (OCD) and 21 healthy controls with fMRI during an emotional face-processing paradigm involving active response generation to test for alterations in both brain activation and task-induced functional connectivity of the frontal cortex, the amygdala and the fusiform face area. The starting point of this study was that patients with anxiety symptoms generally overreact to emotional cues. The results clearly show that patients with OCD showed signifi cantly greater activation of “ face-processing ” regions including the amygdala, fusiform gyrus and dorsolateral prefrontal cortex. The reciprocal connectivity between face-processing regions was enhanced in OCD. Importantly it was detected that there are signifi cant correlations between patients ’ clinical symptom severity and both task-related region activation and network functional connectivity. Treatment Resistent Depression is a major challenge in everyday clinical practice. A few studies have suggested that switching between selective serotonin reuptake inhibitor (SSRI) and tricyclic (TCA) antidepressants may have positive effects on the treatment outcome. Thus Daniel Souery and colleagues have undertaken a prospective study to evaluate the impact of switching strategies. A total of 189 patients who failed to respond to previous antidepressant treatment were included for this study. The results support the thesis that switching from an SSRI to a TCA (and vice versa) in non-responders to a 4-week trial of an SSRI/ TCA is not associated with improved response. Recent studies have evidenced that patients with Bipolar Disorder (BD) show a sensory gating defi cit (P50). Among the neural systems that could be infl uencing this electrophysiological phenotype, dopamine seems to play an important role. In é s Anc í n and Spanish colleagues assume that catecholO -methyltransferase (COMT), the main metabolizer of dopamine in prefrontal cortex, is related to this defi cit. A case – control study was performed in 784 controls and 238 BD patients. Besides, 122 euthymic bipolar subjects and 95 healthy subjects carried out a sensory gating task (P50). The results support the association of the COMT gene with BD and with one of its potential endophenotypes, auditory sensory gating defi cit, measured by the P50 paradigm. Sheng-Yu Lee and colleages from Taiwan present a study on the dopaminergic polymorphims as risk factors for Bipolar Disorders (BD). The authors examined the association between the The World Journal of Biological Psychiatry, 2011; 12: 317–318\",\"PeriodicalId\":22963,\"journal\":{\"name\":\"The World Journal of Biological Psychiatry\",\"volume\":\"64 1\",\"pages\":\"317 - 318\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The World Journal of Biological Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/15622975.2011.602222\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The World Journal of Biological Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/15622975.2011.602222","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

很高兴欢迎大家阅读《金融时报》2011年第五期。Fabrice Jollant及其同事发表了一篇综述文章,探讨了自杀行为中功能失调的认知过程及其神经解剖学基础,以建立一个神经认知工作模型。自杀行为改变的概念不同于共病障碍的概念是支持。作者得出结论,几种神经认知功能障碍,其中一些具有特征特征,可能会促进压力环境下自杀危机的发展:价值归因调节的改变,情绪和认知反应的调节不足,以及情绪环境下行为的促进。这个初步的模型可能代表了一个框架,为未来的研究设计病理生理学,预测和预防这些复杂的人类行为。锂仍然是预防和治疗双相情感障碍的基石,并有助于其他相关精神障碍,如分裂情感性障碍和周期性重度抑郁症。锂盐在60多年前被引入现代精神病学。值此周年纪念之际,Janusz Rybakowski对近年来发表的关于锂的最重要的原创论文和评论进行了更新。锂的促进认知和抗自杀特性已被证实是治疗难治性抑郁症的抗抑郁药物的增强剂。锂的神经保护作用已在实验研究和使用脑成像的临床研究中得到证实。讨论了锂在预防痴呆和神经退行性疾病(如亨廷顿氏病和肌萎缩侧索硬化症)中的可能用途。来自西班牙的Narc í Cardoner及其同事对21名强迫症(OCD)患者和21名健康对照者进行了包括主动反应生成在内的情绪性面部处理范式的fMRI评估,以测试大脑激活和任务诱导的额叶皮质、杏仁核和梭状回面部区域功能连接的变化。这项研究的出发点是,有焦虑症状的患者通常对情绪暗示反应过度。结果清楚地表明,强迫症患者的“面部处理”区域,包括杏仁核、梭状回和背外侧前额皮质,明显更活跃。强迫症患者面部处理区域之间的互通性增强。重要的是,我们发现患者的临床症状严重程度与任务相关区域的激活和网络功能连通性之间存在显著的相关性。治疗难治性抑郁症是日常临床实践中的主要挑战。一些研究表明,在选择性血清素再摄取抑制剂(SSRI)和三环(TCA)抗抑郁药之间切换可能对治疗结果有积极影响。因此,Daniel Souery及其同事进行了一项前瞻性研究,以评估转换策略的影响。本研究共纳入189名既往抗抑郁治疗无效的患者。研究结果支持了从SSRI切换到TCA(反之亦然)的论点,即在对SSRI/ TCA无反应的4周试验中,与改善反应无关。最近的研究表明,双相情感障碍(BD)患者表现出感觉门控缺陷(P50)。在可能影响这种电生理表型的神经系统中,多巴胺似乎起着重要作用。在2008年,Anc í和西班牙同事认为,前额皮质多巴胺的主要代谢物儿茶酚甲基转移酶(COMT)与这种缺陷有关。他们在784名对照组和238名BD患者中进行了病例对照研究。此外,122名身心健康者和95名健康者进行了感觉门控任务(P50)。这些结果支持COMT基因与双相障碍及其潜在的一种内表型(听觉感觉门控缺陷,通过P50范式测量)的关联。来自台湾的李盛宇等研究了多巴胺能多态性作为双相情感障碍(BD)的危险因素。作者研究了2011年《世界生物精神病学杂志》;12: 317 - 318
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The World Journal of Biological Psychiatry vol. 12, issue 5
Dear Colleagues, It is my pleasure to welcome you to the fi fth issue of 2011. Fabrice Jollant and colleagues present a review article on studies exploring dysfunctional cognitive processes and their neuroanatomical basis in suicidal behaviour in order to develop a neurocognitive working model. The concept of alterations in suicidal behaviour distinct from those of comorbid disorders is support. The authors come to the conclusion that several neurocognitive dysfunctions, some with trait-like characteristics, may facilitate the development of a suicidal crisis during stressful circumstances: an altered modulation of value attribution, an inadequate regulation of emotional and cognitive responses, and a facilitation of acts in an emotional context. This preliminary model may represent a framework for the design of future studies on the pathophysiology, prediction and prevention of these complex human behaviours. Lithium continues to be a cornerstone for the prophylaxis and treatment of bipolar disorder and is helpful for other related mental disorders, such as schizoaffective disorder and cyclic major depression. Lithium was introduced to modern psychiatry more than 60 years ago. On the occasion of this anniversary, Janusz Rybakowski presents an update on the most important original papers and reviews on lithium published in the recent years. The pro-cognitive and antisuicidal properties of lithium have been confi rmed as an augmentation of antidepressants in treatment-resistant depression. The neuroprotective effects of lithium have been evidenced in both experimental research and in clinical studies using brain imaging. The possible use of lithium in the prophylaxis of dementia and in neurodegenerative disorders, such as Huntington ' s disease and amyotrophic lateral sclerosis is discussed. Narc í s Cardoner and colleagues from Spain assessed 21 patients diagnosed with ObsessiveCompulsive Disorder (OCD) and 21 healthy controls with fMRI during an emotional face-processing paradigm involving active response generation to test for alterations in both brain activation and task-induced functional connectivity of the frontal cortex, the amygdala and the fusiform face area. The starting point of this study was that patients with anxiety symptoms generally overreact to emotional cues. The results clearly show that patients with OCD showed signifi cantly greater activation of “ face-processing ” regions including the amygdala, fusiform gyrus and dorsolateral prefrontal cortex. The reciprocal connectivity between face-processing regions was enhanced in OCD. Importantly it was detected that there are signifi cant correlations between patients ’ clinical symptom severity and both task-related region activation and network functional connectivity. Treatment Resistent Depression is a major challenge in everyday clinical practice. A few studies have suggested that switching between selective serotonin reuptake inhibitor (SSRI) and tricyclic (TCA) antidepressants may have positive effects on the treatment outcome. Thus Daniel Souery and colleagues have undertaken a prospective study to evaluate the impact of switching strategies. A total of 189 patients who failed to respond to previous antidepressant treatment were included for this study. The results support the thesis that switching from an SSRI to a TCA (and vice versa) in non-responders to a 4-week trial of an SSRI/ TCA is not associated with improved response. Recent studies have evidenced that patients with Bipolar Disorder (BD) show a sensory gating defi cit (P50). Among the neural systems that could be infl uencing this electrophysiological phenotype, dopamine seems to play an important role. In é s Anc í n and Spanish colleagues assume that catecholO -methyltransferase (COMT), the main metabolizer of dopamine in prefrontal cortex, is related to this defi cit. A case – control study was performed in 784 controls and 238 BD patients. Besides, 122 euthymic bipolar subjects and 95 healthy subjects carried out a sensory gating task (P50). The results support the association of the COMT gene with BD and with one of its potential endophenotypes, auditory sensory gating defi cit, measured by the P50 paradigm. Sheng-Yu Lee and colleages from Taiwan present a study on the dopaminergic polymorphims as risk factors for Bipolar Disorders (BD). The authors examined the association between the The World Journal of Biological Psychiatry, 2011; 12: 317–318
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信